000 | 01919 a2200577 4500 | ||
---|---|---|---|
005 | 20250513131754.0 | ||
264 | 0 | _c19971208 | |
008 | 199712s 0 0 eng d | ||
022 | _a1355-6568 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKlimka, A | |
245 | 0 | 0 |
_aA deletion mutant of Pseudomonas exotoxin-A fused to recombinant human interleukin-9 (rhIL-9-ETA') shows specific cytotoxicity against IL-9-receptor-expressing cell lines. _h[electronic resource] |
260 |
_bCytokines and molecular therapy _cSep 1996 |
||
300 |
_a139-46 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aADP Ribose Transferases |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aBacterial Toxins |
650 | 0 | 4 | _aBurkitt Lymphoma |
650 | 0 | 4 |
_aCell Survival _xdrug effects |
650 | 0 | 4 | _aCloning, Organism |
650 | 0 | 4 | _aEscherichia coli |
650 | 0 | 4 |
_aExotoxins _xbiosynthesis |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunotherapy _xmethods |
650 | 0 | 4 |
_aImmunotoxins _xtoxicity |
650 | 0 | 4 |
_aInterleukin-9 _xbiosynthesis |
650 | 0 | 4 | _aMast-Cell Sarcoma |
650 | 0 | 4 | _aMutagenesis, Site-Directed |
650 | 0 | 4 | _aPolymerase Chain Reaction |
650 | 0 | 4 | _aPseudomonas aeruginosa |
650 | 0 | 4 |
_aReceptors, Interleukin _xbiosynthesis |
650 | 0 | 4 | _aReceptors, Interleukin-9 |
650 | 0 | 4 |
_aRecombinant Fusion Proteins _xbiosynthesis |
650 | 0 | 4 |
_aRecombinant Proteins _xbiosynthesis |
650 | 0 | 4 | _aSequence Deletion |
650 | 0 | 4 | _aTransfection |
650 | 0 | 4 | _aTumor Cells, Cultured |
650 | 0 | 4 | _aVirulence Factors |
650 | 0 | 4 | _aPseudomonas aeruginosa Exotoxin A |
700 | 1 | _aBarth, S | |
700 | 1 | _aDrillich, S | |
700 | 1 | _aWels, W | |
700 | 1 | _avan Snick, J | |
700 | 1 | _aRenauld, J C | |
700 | 1 | _aTesch, H | |
700 | 1 | _aBohlen, H | |
700 | 1 | _aDiehl, V | |
700 | 1 | _aEngert, A | |
773 | 0 |
_tCytokines and molecular therapy _gvol. 2 _gno. 3 _gp. 139-46 |
|
999 |
_c9354491 _d9354491 |